Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Motif Bio Plc LSE:MTFB London Ordinary Share GB00BVVT4H71 ORD 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.50 0.40 0.55 - 0.00 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 3.2 -1.5 - 3

Motif Bio Share Discussion Threads

Showing 8726 to 8750 of 9100 messages
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
DateSubjectAuthorDiscuss
18/12/2020
08:19
So Motif got several offers to do a RTO due to companies wanting to get their COViD therapeutics to market. Motif then hire Peel Hunt who have failed over and over gain to realise value for investors despite making huge sums for themselves. Walbrook whom take hundred of thousands of pounds to not reply to investors. Were Peel Hunt brought in as they knew the skeletons? Why use the same company that has failed investors before with their predictions? Makes no sense? Why do Walbrook refuse to answer questions? Does anyone else smell a Graham here?
scottdavid70
18/12/2020
05:17
I heard a rumour that they called Jon Gold at his former jobs the man with the Midas touch....sadly it appears it is only for HIMSELF for investors in Motif Bio
scottdavid70
18/12/2020
05:15
Good morning wonder what Jon “deferred $325,000 salary on top of his current $325,000 for this year despite strict cost controls” Gold is working on today? The man has milked almost $1.5 million in cash from Motif but is yet to buy a share. Shareholders have been propping up is extravagant lifestyle
scottdavid70
17/12/2020
14:45
There a few of us who have contacted the relevant authorities on the legalities of no Board reviews for the members of the Board and also how they acted as one in 2019. We await what the response but every organisation I have been a part of as good Corporate Governance does individual and group reviews no matter the type of year they have had. It’s utterly bemusing they didn’t have any reviews for 2019. Actually it’s incredible
scottdavid70
17/12/2020
11:30
Lumsden too nearly $1.5 million in salary from 2018 and produced what from that outrageous sum? Not only that but he pulled the AGM forward to scurry away from Investors before the FDA revealed that not surprisingly, despite his claim that no new clinical trials were needed on the 19th Feb webcast 2019, that need a whole new Phase iii trial $1.5 million he took of shareholders investment and didn’t have the guts to face them at the AGM. Zero backbone all the at through this disgraceful saga
scottdavid70
17/12/2020
11:26
Where are the US Army trials and if nowhere why not just say so after a year and 2 months? They shout it from the rooftops and then scurry away into their Chateaux’s the moment things get a wee bit tough poor dears
scottdavid70
17/12/2020
11:24
Why when Lumsden said the Lamellare tie up wound yield results in months from May 2019 have we heard nothing still?
scottdavid70
17/12/2020
11:24
For example, how are investors not emailing Motif and Walbrook to ask about the new patents this August for Iclaprim and Sandoz every day? Your investment could depend on what that means but they won’t mention it even happened. Yet they agree there is a contract in place that investors could benefit from via a sale so therefore it stands to reason that the investors here who have been shafted by the Board to date should be informed of the potential upside these patents mean
scottdavid70
17/12/2020
10:52
I will post everyday until the 28th January about what has transpired here
scottdavid70
17/12/2020
10:50
Bi11y - that’s for me to know and the Motif Board to find out one day As for the kitchen - I most definitely wasn’t in it at 5am hunched over. I have lots to do with my life but making sure the Motif Board are not forgotten is definitely a part of it until the 28th January 2021. As I have said previously this is already close to being a finished book and a case study for investors and ultimately Directors in the future.
scottdavid70
17/12/2020
09:02
bi11y ray Valentine- you raise serious questions here. Always have sympathy for those who lose- but you have to let go!!
smcl
17/12/2020
08:56
I'm picturing you in a dark kitchen hunched over a bowl of soggy cornflakes at 5 o'clock this morning, plotting the next phase of your dastardly plan to stick it to the Motif board once again. Serious question, Scott: How much of an affect did the FDA refusal actually have on your life? How bad was it on a scale of 'wife and kids left me and they took the dog too' through to 'my plans to retire to the south of France had to be put on hold a couple of years'?
bi11y ray va1entine
17/12/2020
05:51
That’s YOUR money going in JON GOLDS POCKET
scottdavid70
17/12/2020
05:49
Jon Gold take home pay if a RTO happens in 2 years plus a month OVER $2 MILLION DOLLARS WOW!! Hows is that allowed????
scottdavid70
17/12/2020
05:31
What did Non Good do in 2018 and 2019 to earn almost $1.5 million??????????
scottdavid70
17/12/2020
05:22
Strict cost controls were in pace they told us in 2019: Graham Lumsden pay $464,063 Jon Gold pay $618,388 2018 these two made GL pay $726,639 JG pay $881,517 Total failure ensued Lunsden will get a $100,000 BONUS if a RTO happens and Jon Gold a deferred salary cheque of $325,000!!! GROTESQUE GREED
scottdavid70
16/12/2020
20:15
I see LSE are growing a backbone and they don’t just have to be a collection of Lumsden luvvies. Start with the liver experts on standby and the no clinical trials (they took that webcast down but the recordings are still in private circulation) and work from those statements and the proactive interviews. There is much to ‘unearth’;
scottdavid70
16/12/2020
18:52
Steady Danny is starting to get the penny to drop I see on LSE - what have investors been told with what outcome has transpired. Very interesting times ahead for Jon “and his pot of deferred” Gold and Graham “loaded” Lumsden
scottdavid70
16/12/2020
13:31
Directors would appear to be making it up on the fly - unbelievable stuff gone on here for my book
scottdavid70
16/12/2020
13:30
Loving the investor insight on LSE. Deep dive stuff One asking for two AGM’s which is impressive....and not just a little impossible and total nonsense It’s a General Meeting they have to call muppets and are running out of time fast for that. Don’t forget they will grade their performance after a potential RTO but not on the horrific year shareholders themselves had to suffer due to their decision making.
scottdavid70
16/12/2020
11:11
Lumsdens Luvvies trotting out the all bases covered line on LSE. Their Messiah has it all sorted in their minds...oh the delusions
scottdavid70
16/12/2020
08:52
Also Motif acknowledges it has adopted Quoted Companies Alliance Corporate Governance Code but does not fully comply with the 10 principles and general provisions of the Code. Everything is a moveable feast isn’t it for these guys? No Board evaluation of a horrendous year. How convenient!!!
scottdavid70
16/12/2020
08:18
How many of you knew honestly that Jon Gold is getting $25,000 a month and $25,000 a month deferred until a FTO is completed. CLEARLY MAKES IT BENEFICIAL FOR HIM TO NOT DO A RTO UNTIL NEXT MONTH AS THERE IS HUGGE UPSIDE FOR HIM TO DELAY IT Scandalous these type of incentives but non more so than Lumsdens BONUS of $100,000 if a RTO happens
scottdavid70
15/12/2020
19:26
Undertake it after a RTO to say what amazing Directors we are I assume to achieve a RTO? Just sweeping the whole of the Iclaprim fiasco under the carport then for your reputations?
scottdavid70
15/12/2020
19:24
Did you know in the Annual Accounts it states that the Board didn’t undergo a performance evaluation of the BOD in 2019 or an effectiveness of the BOD but is intending to undertake one following completion of a RTO or qualifying transaction. Must be nice to fail and then not have to be evaluated for that failure but if you then succeed having failed and that success is founded solely on luck and the fact that you originally failed you get a blemish free Cv!!! How many of us would love to work for companies who give that much latitude to failure?
scottdavid70
Chat Pages: Latest  352  351  350  349  348  347  346  345  344  343  342  341  Older
ADVFN Advertorial
Your Recent History
LSE
MTFB
Motif Bio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210225 10:14:54